Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2011 / Cilt: 21 - Sayı: 3

Effects of grape seed extract and origanum onites essential oil on cisplatin-ınduced hepatotoxicity in rats

Pages
133–140
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion GSE and OOEO may be used in adjuvant therapy to prevent cisplatin–induced hepatotoxicity, but further studies using various doses, different time intervals, and a larger number of animals need to be carried out.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cisplatin is a widely used anticancer drug but, it can produce undesirable effects such as hepatotoxicity even in therapeutic doses.
📊
Key Findings & Data:Ninetysix–male Wistar albino rats were divided into eight groups, twelve in each (Cont- rol, GSE, OOEO, GSE+OOEO, Cisplatin, GSE+ Cisplatin, OOEO+ Cisplatin, GSE+OOEO+ Cisplatin) and followed up for 10 days.
💡
Conclusion & Impact:In conclusion GSE and OOEO may be used in adjuvant therapy to prevent cisplatin–induced hepatotoxicity, but further studies using various doses, different time intervals, and a larger number of animals need to be carried out.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Cisplatin is a widely used anticancer drug but, it can produce undesirable effects such as hepatotoxicity even in therapeutic doses. The underlying mechanism in hepatotoxicity has been attributed to free oxygen radicals. The present study was de- signed to determine the possible protective effects of grape seed extract (GSE) and Origanum onites essential oil (OOEO) on liver toxicity induced by cisplatin. Ninetysix&#8211;male Wistar albino rats were divided into eight groups, twelve in each (Cont- rol, GSE, OOEO, GSE+OOEO, Cisplatin, GSE+ Cisplatin, OOEO+ Cisplatin, GSE+OOEO+ Cisplatin) and followed up for 10 days. Cisplatin and OOEO were injected intraperitoneally. GSE was administered with gavage. The histopathological exami- nation of liver tissues was performed by light microscope. Superoxide dismutase (SOD), glutathione peroxidase (GSH&#8211;Px) activities and malondialdehyde (MDA) levels were determined in liver tissues. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured in serum. Cisplatin-induced considerable hepatocyte damage under micros- copic examination, and an increase in MDA levels as well as a decrease in the activities of antioxidant enzymes, including SOD, GSH&#8211;Px in liver tissues and an increase in serum ALT and AST (p< 0.001). The addition of GSE and/or OOEO signi- ficantly prevented microscopic tissue damage, reversed oxidative stress parameters and biochemical values compared to the cisplatin group (p< 0.001). In conclusion GSE and OOEO may be used in adjuvant therapy to prevent cisplatin&#8211;induced hepatotoxicity, but further studies using various doses, different time intervals, and a larger number of animals need to be carried out.

Özet

Sisplatin, kanser tedavisinde yaygın olarak kullanılan fakat tedavi dozlarında dahi karaciğer hasarı gibi istenmeyen yan etkile- re sebep olabilen bir ilaçtır. Sisplatinin karaciğer dokusunda yaptığı hasarın altında yatan mekanizma büyük oranda serbest oksijen radikallerine bağlıdır. Bu çalıflmada sıçanlarda sisplatin tedavisine bağlı oluflan karaciğer hasarında üzüm çekirdeği özütünün (ÜÇÖ) ve esansiyel kekik yağının (EKY) muhtemel koruyucu etkilerinin arafltırılması amaçlanmıfltır. Doksanaltı adet Wistar albino cinsi erkek sıçan; her biri oniki hayvandan oluflan sekiz gruba bölünerek (Kontrol, ÜÇÖ, EKY, ÜÇÖ+EKY, Sisp- latin, ÜÇÖ+Sisplatin, EKY+Sisplatin, ÜÇÖ+EKY+Sisplatin), on gün süreyle takip edildi. Sisplatin, kanser tedavisinde yaygın olarak kullanılan fakat tedavi dozlarında dahi karaciğer hasarı gibi istenmeyen yan etkile- re sebep olabilen bir ilaçtır. Sisplatinin karaciğer dokusunda yaptığı hasarın altında yatan mekanizma büyük oranda serbest oksijen radikallerine bağlıdır. Bu çalıflmada sıçanlarda sisplatin tedavisine bağlı oluflan karaciğer hasarında üzüm çekirdeği özütünün (ÜÇÖ) ve esansiyel kekik yağının (EKY) muhtemel koruyucu etkilerinin arafltırılması amaçlanmıfltır. Doksanaltı adet Wistar albino cinsi erkek sıçan; her biri oniki hayvandan oluflan sekiz gruba bölünerek (Kontrol, ÜÇÖ, EKY, ÜÇÖ+EKY, Sisp- latin, ÜÇÖ+Sisplatin, EKY+Sisplatin, ÜÇÖ+EKY+Sisplatin), on gün süreyle takip edildi.

🔖

Cite This Article

ÇETİN, A., ARSLANBAŞ, Ü., SARAYMEN, B., CANÖZ, Ö., ÖZTÜRK, A., SAĞDIÇ, O. (2011). Effects of grape seed extract and origanum onites essential oil on cisplatin-ınduced hepatotoxicity in rats. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 21 - Sayı: 3, 133–140. https://ajindex.com/articles/323277

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Tsang RY, Al-Fayea T, Au HJ. Cisplatin overdose: To- xicities and management. Drug Saf 32: 1109-1122, 2009 2. Greggi ALM, Darin JD, Bianchi M. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats. Pharmacol Res 41 405-411, 2000. 3. Screnci D, McKeage MJ. Platinum neurotoxicity: Clini cal profiles, experimental models and neuroprotectiv approaches. J Inorg Biochem 77: 105-110,1999. 4. Cersimo RJ. Hepatotoxicity associated with cisplatin chemotherapy. Ann Pharm 27: 438-441,1993. 5. Cavalli F, Tschopp L, Sonntag RW, Zimmermann A. A case of liver toxicity following cis-dichlorodiamminep- latinum(II) treatment. Cancer Treat Rep 62: 2125- 2126, 1978. 6. Pollera CF, Ameglio F, Nardi M, et al. Cisplatin induced hepatic toxicity. J Clin Oncol 5: 318-319, 1987 7. Sayyad HI, Ismail MF, Shalaby FM, et al. Histopatholo- gical effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats Int J Biol Sci 5: 466-473, 2009. 8. Fadillioglu E, Oztas E, Erdogan H, et al. Protective ef- fects of caffeic acid phenethyl ester on doxorubicin in- duced cardiotoxicity in rats. J App Toxicol 24: 47-52, 2004. 9. Fadillioglu E, Erdogan H. Effects of erdosteine treat- ment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats. Pharmacol Res 47: 317-322, 2003. 10. Blakley BW, Cohen JI, Doolittle ND, et al. Strategies for prevention of toxicity caused by platinum-based che- motherapy. Laryngoscope 112: 1997-2001, 2002. 11. Weijl NI, Elsendoorn TJ, Lentjes EG, et al. Supplemen- tation with antioxidant micronutrients and chemothe- rapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double- blind, placebo-controlled study. Eur J Cancer 40: 1713-23, 2004. 12. Naz›roglu M, Karaoglu A, Aksoy OA. Selenium and high dose vitamin E administration protects cisplatin- induced oxidative damage to renal, liver and lens tis- sues in rats. Toxicology 195: 221-230, 2004. 13. Custodio JB, Cardoso CM, Santos MS, et al. Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: Prevention by thiol group protecting agents. Toxicology 2: 18-24, 2009. 14. Bagchi D, Bagchi M, Stohs SJ, et al. Free radicals and grape seed proanthocyanidin extract: Importance in human health and disease prevention. Toxicology 148: 187-197, 2000. 15. Cetin A, Sagdic O. A Concise Review: Antioxidant Ef- fects